Aligos Therapeutics, Inc. (ALGS) Cash flow
Market cap
$5.12M
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 3 | 13 | 15 | 13 | 8 |
| Cash from operations | -74 | -116 | -79 | -79 | -81 |
| Capital expenditures | -2 | -1 | -1 | -0 | -0 |
| Cash from investing | 33 | 3 | -26 | 45 | -18 |
| Cash from financing | 192 | 79 | 0 | 88 | 0 |
| Free cash flow | |||||
| FCF margin (%) | - | - | - |